TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34161946

Group type: EXPERIMENTAL
Intervention: Video-based mHealth program (3-month program with nurse case management and video messages)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Video-based mHealth program
Number of subjects: 68

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 68
Study: 35740202

Group type: EXPERIMENTAL
Intervention: Ivermectin (400–600 µg/kg/d)
Number of subjects: 983

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 983
Study: 32531070

Group type: EXPERIMENTAL
Intervention: Desflurane (desflurane/remifentanil)
Number of subjects: 67

Group type: COMPARATOR
Intervention: TIVA (propofol/remifentanil)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Sevoflurane (sevoflurane/remifentanil)
Number of subjects: 67
Study: 35195045

Group type: EXPERIMENTAL
Intervention: Handgrip exercise (30 minutes)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (time-control)
Number of subjects: 11
Study: 33598997

Group type: EXPERIMENTAL
Intervention: Training session for compression bandaging
Number of subjects: 55
Study: 36267612

Group type: EXPERIMENTAL
Intervention: 10 mg of hyperbaric bupivacaine (0.5%)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 12 mg of hyperbaric bupivacaine (0.5%)
Number of subjects: 40
Study: 35358097

Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy
Number of subjects: 298

Group type: COMPARATOR
Intervention: Standard gauze dressing
Number of subjects: 298
Study: 33151698

Group type: EXPERIMENTAL
Intervention: Nicotine ingestion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nicotine abstinence
Number of subjects: 0
Study: 32543162

Group type: EXPERIMENTAL
Intervention: Alternate nostril breathing (ANB) exercise for 4 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study: 33597131

Group type: EXPERIMENTAL
Intervention: ACC/AHA 2017 guideline recommendation for antihypertensive medication
Number of subjects: 3092

Group type: COMPARATOR
Intervention: JNC7 guideline recommendation for antihypertensive medication
Number of subjects: 3092

Group type: COMPARATOR
Intervention: ESH/ESC 2013 guideline recommendation for antihypertensive medication
Number of subjects: 3092

Group type: COMPARATOR
Intervention: ESC/ESH 2018 guideline recommendation for antihypertensive medication
Number of subjects: 3092

Group type: COMPARATOR
Intervention: WHO/ISH 2003 guideline recommendation for antihypertensive medication
Number of subjects: 3092

Group type: COMPARATOR
Intervention: ISH 2020 guideline recommendation for antihypertensive medication
Number of subjects: 3092
Study: 32246196

Group type: EXPERIMENTAL
Intervention: Psychoeducation
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Combination of psychoeducation and cognitive behavioral therapy (CBT)
Number of subjects: 373

Group type: COMPARATOR
Intervention: Combination of psychoeducation and CBT
Number of subjects: 373
Study: 33719692

Group type: EXPERIMENTAL
Intervention: Wording condition: refusal
Number of subjects: 175

Group type: COMPARATOR
Intervention: Wording condition: not willing/non-consent
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Men's interpretations
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Women's interpretations
Number of subjects: 175
Study: 32341113

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 283

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 283
Study: 37640651

Group type: EXPERIMENTAL
Intervention: Laparoscopic off-clamp tumor evacuation (Group 2)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Laparoscopic standard nephron-sparing surgery (Group 1)
Number of subjects: 42
Study: 32890442

Group type: EXPERIMENTAL
Intervention: Bioresorbable polymer sirolimus eluting stent (BP‐SES)
Number of subjects: 3717

Group type: COMPARATOR
Intervention: Durable polymer everolimus eluting stent (DP‐EES)
Number of subjects: 3717
Study: 33720588

Group type: EXPERIMENTAL
Intervention: Polydexa with phenylephrinum (topical nasal spray)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Systemic antibacterial therapy and long‐acting local decongestants
Number of subjects: 100
Study: 35760691

Group type: COMPARATOR
Intervention: General anesthesia with propofol and opioids (Group A)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: General anesthesia with propofol and opioids plus interfascial blocks (Group B)
Number of subjects: 103
Study: 34527615

Group type: EXPERIMENTAL
Intervention: Indomethacin + Methocarbamol (Group I + M)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Indomethacin (Group I)
Number of subjects: 64
Study: 32734844

Group type: EXPERIMENTAL
Intervention: HS‐UnSS (holding a hockey stick in a flexed posture)
Number of subjects: 12

Group type: COMPARATOR
Intervention: UnSS (traditional unanticipated sidestepping)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HS‐UnSS
Number of subjects: 12
Study: 33823786

Group type: EXPERIMENTAL
Intervention: Group TAP (20 mL of 0.5% ropivacaine per side)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Group Control (normal saline)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Group TAP
Number of subjects: 82

Group type: COMPARATOR
Intervention: Group Control
Number of subjects: 82
Study: 34862870

Group type: EXPERIMENTAL
Intervention: Amiodarone combined with atorvastatin
Number of subjects: 90

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 90
Study: 33181534

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo vaginal ring
Number of subjects: 35
Study: 35661491

Group type: EXPERIMENTAL
Intervention: Active cTBS (20 sessions, 2 per day for 2 weeks)
Number of subjects: 59
Study: 35996776

Group type: EXPERIMENTAL
Intervention: Sutureless glue free conjunctival autograft
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sutured (vicryl 8‐0) conjunctival autograft
Number of subjects: 100
Study: 32242289

Group type: EXPERIMENTAL
Intervention: 2-h LINKS
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 1-h LINKS
Number of subjects: 84

Group type: COMPARATOR
Intervention: 1-h Active Control
Number of subjects: 84

Group type: COMPARATOR
Intervention: 2-h Active Control
Number of subjects: 84
Study: 35411186

Group type: EXPERIMENTAL
Intervention: Low Serratus Anterior Plane Block (SAPB) with 40 mL 0.375% ropivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo control with normal saline
Number of subjects: 40
Study: 34561541

Group type: EXPERIMENTAL
Intervention: Green tea combined with α-glucosyl hesperidin (GT-gH)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35413933

Group type: EXPERIMENTAL
Intervention: HCV self-testing via online distribution (oral fluid- or blood-based HCV self-test kit mailed)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: HCV self-testing via online distribution
Number of subjects: 750

Group type: COMPARATOR
Intervention: Standard care (clinic-based HCV antibody testing)
Number of subjects: 750
Study: 32975624

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with SSNB and ANB (Group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: SSNB and ANB alone (Group 2)
Number of subjects: 40
Study: 32740723

Group type: EXPERIMENTAL
Intervention: Announced exercise with 33% reduction in meal bolus (A-RB)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Announced exercise with full meal bolus (A-FB)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Unannounced exercise with full meal bolus (U-FB)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Comparison of A-RB vs U-FB
Number of subjects: 37
Study: 36005503

Group type: EXPERIMENTAL
Intervention: 2 g/day SXRG84 for six weeks
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 4 g/day SXRG84 for six weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo for six weeks followed by 2 g/day SXRG84 for six weeks (Study 2)
Number of subjects: 64
Study: 34520311

Group type: EXPERIMENTAL
Intervention: 3.5-h time interval
Number of subjects: 70

Group type: COMPARATOR
Intervention: 4-h time interval
Number of subjects: 70
Study: 35199421

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 527

Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 527
Study: 34654349

Group type: EXPERIMENTAL
Intervention: ZSP1273 (single or multiple doses)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35245416

Group type: EXPERIMENTAL
Intervention: Arthroscopic Partial Meniscectomy (APM)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Physical Therapy
Number of subjects: 302
Study: 32919076

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 199

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 199
Study: 32240370

Group type: EXPERIMENTAL
Intervention: Parent Child Interaction Therapy Emotion Development (PCIT-ED)
Number of subjects: 0
Study: 34628482

Group type: EXPERIMENTAL
Intervention: 20 mg JNJ-48816274
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 50 mg JNJ-48816274
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 34673259

Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 65

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 65
Study: 32658921

Group type: EXPERIMENTAL
Intervention: Cryotherapy treatment for hrHPV positive women
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Provider perceptions of barriers to treatment
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Facilitators of treatment
Number of subjects: 16
Study: 35380718

Group type: EXPERIMENTAL
Intervention: Intravenous iron supplementation
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Functional tests
Number of subjects: 186
Study: 34336894

Group type: COMPARATOR
Intervention: Rabeprazole 10 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Anaprazole 20 mg
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Anaprazole 40 mg
Number of subjects: 150
Study: 36361056

Group type: EXPERIMENTAL
Intervention: Self-construction of materials (SELF)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 111
Study: 32987282

Group type: EXPERIMENTAL
Intervention: High emotional arousal (measured by fundamental frequency, f0) during rationale development
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Insight into the rationale (assessed by raters)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Symptom severity (self- and rater assessed at beginning and end of therapy)
Number of subjects: 197
Study: 34255325

Group type: EXPERIMENTAL
Intervention: Traditional configuration
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Traditional to failure
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Rest-pause
Number of subjects: 28

Group type: COMPARATOR
Intervention: Inter-repetition rest
Number of subjects: 28
Study: 33991479

Group type: EXPERIMENTAL
Intervention: Annual multimodal screening (MMS)
Number of subjects: 202562

Group type: EXPERIMENTAL
Intervention: Annual transvaginal ultrasound screening (USS)
Number of subjects: 202562

Group type: COMPARATOR
Intervention: No screening
Number of subjects: 202562
Study: 33016149

Group type: EXPERIMENTAL
Intervention: Xiangshao granules
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 32803641

Group type: EXPERIMENTAL
Intervention: Transvenous phrenic nerve stimulation with the remedē System
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35669366

Group type: EXPERIMENTAL
Intervention: Psychological support intervention based on structure‐process‐result three‐dimensional quality assessment
Number of subjects: 110

Group type: COMPARATOR
Intervention: Routine nursing measures (Control)
Number of subjects: 110
Study: 33894334

Group type: EXPERIMENTAL
Intervention: Active left dorsolateral prefrontal cortex (DLPFC) tDCS
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham DLPFC-tDCS
Number of subjects: 19
Study: 33050897

Group type: EXPERIMENTAL
Intervention: BREN+AVD (brentuximab vedotin + AVD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)
Number of subjects: 0
Study: 33784487

Group type: EXPERIMENTAL
Intervention: FitSkills exercise program (12 weeks, twice-weekly sessions)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: FitSkills exercise program
Number of subjects: 163
Study: 33666166

Group type: EXPERIMENTAL
Intervention: Portable monitor (PM) sleep testing at home
Number of subjects: 20

Group type: COMPARATOR
Intervention: Portable monitor (PM) sleep testing in-laboratory
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Patient satisfaction with PM
Number of subjects: 20
Study: 33999545

Group type: EXPERIMENTAL
Intervention: FFR-guided complete revascularization
Number of subjects: 1163

Group type: COMPARATOR
Intervention: Angiography-guided complete revascularization
Number of subjects: 1163
Study: 36115888

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg subcutaneously every 6 months
Number of subjects: 279

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 279
Study: 32675674

Group type: EXPERIMENTAL
Intervention: Complete repair with posterior interval slide
Number of subjects: 58

Group type: COMPARATOR
Intervention: Partial repair without posterior interval slide
Number of subjects: 58
Study: 34086998

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 147

Group type: COMPARATOR
Intervention: Palpation and landmarks (Control)
Number of subjects: 147
Study: 32356115

Group type: EXPERIMENTAL
Intervention: Abatacept 125 mg weekly for 24 weeks
Number of subjects: 424

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 424
Study: 35035429

Group type: EXPERIMENTAL
Intervention: Lipid based nutritional supplement for pregnant and lactating women LNS-PLW
Number of subjects: 60
Study: 32810850

Group type: EXPERIMENTAL
Intervention: Probiotic alone
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Probiotic plus antispasmodic
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 35614509

Group type: EXPERIMENTAL
Intervention: Multicomponent LIVE intervention (including medication review by the PwD’s regular GPs)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Health care as usual (control condition)
Number of subjects: 280
Study: 36398582

Group type: EXPERIMENTAL
Intervention: Optimal early mobility training regimens
Number of subjects: 2700

Group type: COMPARATOR
Intervention: Reference arm (usual mobility training)
Number of subjects: 2700
Study: 34889235

Group type: EXPERIMENTAL
Intervention: modified GGQL formula plus basic antitumor therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: basic antitumor therapy
Number of subjects: 120
Study: 34197772

Group type: EXPERIMENTAL
Intervention: Emtricitabine and tenofovir alafenamide (200/25 mg)
Number of subjects: 5387

Group type: COMPARATOR
Intervention: Emtricitabine and tenofovir disoproxil fumarate (200/300 mg)
Number of subjects: 5387

Group type: EXPERIMENTAL
Intervention: Emtricitabine and tenofovir alafenamide
Number of subjects: 5387
Study: 34941609

Group type: COMPARATOR
Intervention: Traditional squats (TRAD)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Traditional plus modified squats (EXP)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both groups (TRAD and EXP)
Number of subjects: 37
Study: 36129997

Group type: EXPERIMENTAL
Intervention: Insulin glargine U-100
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Glimepiride
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Overall rates of moderately increased albuminuria
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Overall rates of severely increased albuminuria
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Overall rates of renal impairment
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Overall rates of diabetic peripheral neuropathy
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: MACE (major adverse cardiovascular events)
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Hospitalization for heart failure
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Death from cardiovascular causes
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: All deaths
Number of subjects: 5047
Study: 33378703

Group type: EXPERIMENTAL
Intervention: Functional substrate ablation
Number of subjects: 40
Study: 33017685

Group type: EXPERIMENTAL
Intervention: Retrograde filling of the bladder with 200 mL of saline before catheter removal
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard care (immediate catheter removal)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 34376488

Group type: EXPERIMENTAL
Intervention: Aortic valve calcification (AVC) scores
Number of subjects: 14073

Group type: EXPERIMENTAL
Intervention: Cardiovascular risk factors
Number of subjects: 14073
Study: 32856785

Group type: EXPERIMENTAL
Intervention: Postoperative concurrent aerobic and resistance training for 12 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 49
Study: 36079794

Group type: EXPERIMENTAL
Intervention: 4 g/day n3-PUFA
Number of subjects: 63

Group type: COMPARATOR
Intervention: Corn oil placebo
Number of subjects: 63
Study: 33162260

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 14
Study: 32205572

Group type: EXPERIMENTAL
Intervention: Serratus anterior plane blocks
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Paravertebral blocks
Number of subjects: 90

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 90
Study: 35598544

Group type: EXPERIMENTAL
Intervention: 240 mg of saccharin
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 75 g of sucrose
Number of subjects: 9

Group type: COMPARATOR
Intervention: 300 ml of water
Number of subjects: 9
Study: 32240035

Group type: EXPERIMENTAL
Intervention: TaTME
Number of subjects: 38

Group type: COMPARATOR
Intervention: LapTME
Number of subjects: 38
Study: 32308200

Group type: EXPERIMENTAL
Intervention: 4-month exercise training programme
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 90
Study: 35657320

Group type: EXPERIMENTAL
Intervention: ctDNA-guided management
Number of subjects: 455

Group type: COMPARATOR
Intervention: standard management
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: ctDNA-positive patients receiving adjuvant chemotherapy
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: ctDNA-negative patients not receiving adjuvant chemotherapy
Number of subjects: 455
Study: 32528151

Group type: EXPERIMENTAL
Intervention: Identical meals
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Gut microbiome
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Meal macronutrients
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Genetic variants
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Machine-learning model
Number of subjects: 1002
Study: 35487736

Group type: EXPERIMENTAL
Intervention: Combination of light acupuncture treatment and five-element music therapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: No treatment group
Number of subjects: 36
Study: 33852330

Group type: EXPERIMENTAL
Intervention: Dual-energy CT (DECT)-based nomogram
Number of subjects: 206
Study: 34809440

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI)
Number of subjects: 40
Study: 34548372

Group type: EXPERIMENTAL
Intervention: Cognitive-bias modification intervention (12-session training programme over 3 weeks)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Control condition (placebo)
Number of subjects: 308
Study: 32248820

Group type: EXPERIMENTAL
Intervention: systematic maintenance rTMS (M-rTMS) for responders (arm A)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: additional new rTMS cure in case of mood deterioration among responders (arm B)
Number of subjects: 318

Group type: COMPARATOR
Intervention: placebo arm (arm C)
Number of subjects: 318
Study: 36153330

Group type: EXPERIMENTAL
Intervention: TAK-653 0.5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: TAK-653 6 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32866238

Group type: EXPERIMENTAL
Intervention: Nicotine exposure from nonstaff NICU visitors' fingers
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Bedside furniture nicotine contamination
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Infant cotinine measures
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Participants with household nicotine use
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Bayesian univariate regressions
Number of subjects: 210
Study: 33433363

Group type: EXPERIMENTAL
Intervention: Anticipated delay in help-seeking for persistent cough
Number of subjects: 1895

Group type: EXPERIMENTAL
Intervention: Anticipated delay in help-seeking for rectal bleeding
Number of subjects: 1895

Group type: EXPERIMENTAL
Intervention: Anticipated delay in help-seeking for breast changes
Number of subjects: 1895
Study: 35210132

Group type: EXPERIMENTAL
Intervention: 14 mg lenvatinib plus everolimus 5 mg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: 18 mg lenvatinib plus everolimus 5 mg/d
Number of subjects: 0
Study: 32844806

Group type: EXPERIMENTAL
Intervention: Early feeding group
Number of subjects: 50
Study: 34398312

Group type: EXPERIMENTAL
Intervention: Aquatic exercises in a 33 °C spa pool, 5 days a week for 2 weeks, 20 min per day
Number of subjects: 43

Group type: COMPARATOR
Intervention: Non-aquatic exercises (walking out of the pool and strengthening/stretching exercises), 5 days a week for 2 weeks, 20 min per day
Number of subjects: 43
Study: 33294894

Group type: EXPERIMENTAL
Intervention: Education-Based Intervention Program (EBIP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 40
Study: 34146510

Group type: EXPERIMENTAL
Intervention: 100% ONS stimulation
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 30% ONS stimulation
Number of subjects: 150

Group type: COMPARATOR
Intervention: Both 100% and 30% ONS
Number of subjects: 150
Study: 33724323

Group type: EXPERIMENTAL
Intervention: EPA-DHA (460 mg/d of EPA and 380 mg/d of DHA)
Number of subjects: 25119

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/d)
Number of subjects: 25119

Group type: COMPARATOR
Intervention: Placebo for EPA-DHA
Number of subjects: 25119

Group type: COMPARATOR
Intervention: Placebo for Vitamin D3
Number of subjects: 25119